Literature DB >> 312800

Purification of a colony-stimulating factor from cultured pancreatic carcinoma cells.

M Wu, J K Cini, A A Yunis.   

Abstract

Serum-free conditioned medium prepared from an established line of human pancreatic carcinoma (MIA PaCa-2) provides a rich source of colony-stimulating factor (CSF). Two activities distinctly separable by isoelectrofocusing have been identified: a high molecular weight CSF exhibiting greater activity in mouse bone marrow and a low molecular weight CSF more active in human bone marrow. The high molecular weight CSF has been purified 1000-fold to apparent homogeneity by a two-step procedure including isoelectrofocusing and gel filtration chromatography. The purified CSF has a molecular weight of 50,000 and an isoelectric point of 3.7 to 4.6. It is a glycoprotein as shown by periodic acid-Schiff stain and exhibits greater activity in mouse marrow than in human marrow.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312800

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Granulocyte-colony stimulating factor produced by pancreatic carcinoma.

Authors:  T Uematsu; K Tsuchie; K Ukai; E Kimoto; T Funakawa; R Mizuno
Journal:  Int J Pancreatol       Date:  1996-04

2.  Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case.

Authors:  Akihisa Matsuda; Koji Sasajima; Takeshi Matsutani; Hiroshi Maruyama; Masayuki Miyamoto; Tadashi Yokoyama; Seiji Suzuki; Hideyuki Suzuki; Takashi Tajiri
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

3.  Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor.

Authors:  Kazuya Endo; Shunji Kohnoe; Takeshi Okamura; Masaru Haraguchi; Eisuke Adachi; Yasushi Toh; Hideo Baba; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

4.  Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.

Authors:  Isamu Ishiwata; Isao Ono; Kazushige Kiguchi; Chieko Ishiwata; Masayuki Soma; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

5.  Preparative purification of human placental colony-stimulating factors.

Authors:  T Schlunk; M Schleyer
Journal:  Blut       Date:  1983-10

6.  Common pattern of two distinct types of colony-stimulating factor in human tissues and cultured cells.

Authors:  M C Wu; A A Yunis
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

7.  Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor.

Authors:  M A Cantrell; D Anderson; D P Cerretti; V Price; K McKereghan; R J Tushinski; D Y Mochizuki; A Larsen; K Grabstein; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Immunological and functional differences between human type I and II colony-stimulating factors.

Authors:  M C Wu; A M Miller; A A Yunis
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Karyotype and ultrastructure of a colony stimulating factor (CSF) producing cell line (5637) originated from a carcinoma of the human urinary bladder.

Authors:  K H Pflüger; H D Probeck; G Adler; D Stach-Machado; H Kapmeyer; K Havemann
Journal:  Blut       Date:  1986-08

10.  Glutamine promotes colony formation in bone marrow and HL-60 cells; accelerates myeloid differentiation in induced HL-60 cells.

Authors:  P D Dass; F E Murdoch; M C Wu
Journal:  In Vitro       Date:  1984-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.